Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acetylcholinesterase (Homo sapiens (Human)) | BDBM476179 ((−)-N1, N8-bisnorphenylcarbamoyleseroline | ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
Aristea Translational Medicine Corporation US Patent | Assay Description To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To... | US Patent US10864192 (2020) BindingDB Entry DOI: 10.7270/Q2TT4V23 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Acetylcholinesterase (Homo sapiens (Human)) | BDBM476174 ((−)-N1-norphenylcarbamoyleseroline | US10864...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 62 | n/a | n/a | n/a | n/a |
Aristea Translational Medicine Corporation US Patent | Assay Description To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To... | US Patent US10864192 (2020) BindingDB Entry DOI: 10.7270/Q2TT4V23 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Acetylcholinesterase (Homo sapiens (Human)) | BDBM10958 ((3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | n/a | n/a | 25 | n/a | n/a | n/a | n/a |
Aristea Translational Medicine Corporation US Patent | Assay Description To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To... | US Patent US10864192 (2020) BindingDB Entry DOI: 10.7270/Q2TT4V23 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Acetylcholinesterase (Homo sapiens (Human)) | BDBM476178 ((−)-N8-norphenylcarbamoyleseroline | US10864...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 62 | n/a | n/a | n/a | n/a |
Aristea Translational Medicine Corporation US Patent | Assay Description To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To... | US Patent US10864192 (2020) BindingDB Entry DOI: 10.7270/Q2TT4V23 | |||||||||||
More data for this Ligand-Target Pair |